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A 52-year-old woman was admitted to the Department of Hypertension with resistant hypertension coexistent with 
type 2 diabetes mellitus, two episodes of transient ischaemic attack in the past, and obesity. The patient’s arterial hyperten-
sion was uncontrolled on six antihypertensive medications. A denervation procedure Simplicity cathether (Medtronic) was 
applied. In the main left renal artery, six ablations were performed without any complications. During the first ablation of 
the main right renal artery, oedema of the arterial wall with a significant stenosis of 80% occurred. Due to the above, no 
further ablations were attempted. A follow-up arteriography of the right renal artery was performed 24 h later, showing 
a minimal stenosis in the previously affected area. On the qualification visit, the average office blood pressure (BP) was 
203.33/107.66 mm Hg, and on ambulatory BP monitoring mean BP was 189/109 mm Hg in the day and 139/77 mm Hg 
in the night. In the central BP measurement (Sphygmocor, AtCor Medical), systolic BP was 172 mm Hg, diastolic BP 
— 98 mm Hg, augmentation index (AIx) — 40, AIx standarised to a heart rate of 75 bpm (AIx@HR75) — 40% (Fig. 1A). 
In the follow-up visits after six and 12 months, we observed significant falls in all measured parameters (Table 1, Fig. 1B). 
There was no modification of antihypertensive therapy in the follow up. There are just a few publications concerning 
unilateral renal denervation, and the presented results are contradictory. The measurement of central BP in hypertensive 
patients is of increasing interest because of both its predictive value for cardiovascular events and the differential effect 
of antihypertensive therapies compared to brachial BP. In our opinion, central BP should be considered as a valuable 
and objective marker of the effectiveness of invasive therapies. Our case shows that even unilateral renal ablation can 
be fully successful and decrease BP values to a remarkable extent in a 12 month observation. 
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Figure 1. Results of central blood pressure me-
asurement — baseline (A) and after unilateral 
denervation (12 months) (B)
Table 1. Results of blood pressure (BP) measurements (office BP, ambulato-
ry BP monitoring [ABPM], central BP) on baseline visit before denervation 
and two control visits, after six and 12 months
Baseline Visit 1: after 
six months




Office BP: systolic BP 203 180 156 –47
Office BP: diastolic BP 108 98 88 –20
ABPM: day systolic BP 189 150 148 –45
ABPM: day diastolic BP 107 89 90 –17
ABPM: night systolic BP 139 129 128 –11
ABPM: night diastolic BP 77 71 71 –6
SpAo 172 156 145 –27
DpAo 98 96 84 –14
PPAo 74 60 61 –13
Augmentation index 40 41 54 14
AIx@HR75 40% 37% 51% 11
SpAo — aorta (central) systolic blood pressure; DpAo — aorta (central) diastolic blood 
pressure; PPAo — aorta (central) pulse pressure; AIx@HR75 — augmentation index 
standa rised to a heart rate of 75 bpm
A
B
